| Losses per share |
Share data have been revised to give
effect to the share split as explained in Note 4 b) (d).
| | |
Year ended December 31, 2023 | |
| | |
Amount after income tax | | |
Weighted average
number of ordinary
shares outstanding | | |
Losses per share | |
| Basic earnings per share | |
| | |
| | |
| |
| Loss attributable to equity holders of the Company | |
$ | (804,977 | ) | |
| 920,588 | | |
$ | (0.87 | ) |
| Diluted earnings per share | |
| | | |
| | | |
| | |
| Loss attributable to ordinary shareholders of the Company plus assumed conversion of all dilutive potential ordinary shares | |
$ | (804,977 | ) | |
| 920,588 | | |
$ | (0.87 | ) |
| Note: | For the year ended December 31, 2023, there was 96,753 potential shares derived from employee stock options
(19,847 shares), and convertible preferred shares (76,906 shares) outstanding to be issued, which were not included in the calculation
of diluted earnings per shares as their inclusion would have been anti-dilutive. |
| | |
Year ended December 31, 2024 | |
| | |
Amount after income tax | | |
Weighted average
number of ordinary
shares outstanding | | |
Losses
per share | |
| Basic losses per share | |
| | |
| | |
| |
| Loss attributable to equity holders of the Company (Note 1) | |
$ | (85,004,692 | ) | |
| 1,227,064 | | |
$ | (69.27 | ) |
| Diluted losses per share | |
| | | |
| | | |
| | |
| Loss attributable to ordinary shareholders of the Company plus assumed conversion of all dilutive potential ordinary shares (Note 2) | |
$ | (85,004,692 | ) | |
| 1,227,064 | | |
$ | (69.27 | ) |
| Note 1: | For the year ended December 31, 2024, shares to be issued
including deferred shares consideration for the Green Quest acquisition and commitment shares from the Tumim ELOC SPA are included in
the calculation of basic earnings per shares. |
| Note 2: | For the year ended December 31, 2024, there was 864,216 potential
shares derived from employee stock options (20,304 shares), restricted stock unit (695 shares), warrants (841,629 shares) and convertible
note (1,588 shares) outstanding to be issued, which were not included in the calculation of diluted earnings per shares as their inclusion
would have been anti-dilutive. |
| | |
Year ended December 31, 2025 | |
| | |
Amount after income tax | | |
Weighted average
number of ordinary
shares outstanding | | |
Losses
per share | |
| Basic losses per share | |
| | |
| | |
| |
| Loss attributable to equity holders of the Company (Note 1) | |
$ | (44,550,818 | ) | |
| 1,719,527 | | |
$ | (25.91 | ) |
| Diluted losses per share | |
| | | |
| | | |
| | |
| Loss attributable to ordinary shareholders of the Company plus assumed conversion of all dilutive potential ordinary shares (Note 2) | |
$ | (44,550,818 | ) | |
| 1,719,527 | | |
$ | (25.91 | ) |
| Note : | For the year ended December 31, 2025, there was 21,405 potential shares
derived from restricted stock unit (2,486 shares) and convertible note (18,919 shares) outstanding to be issued, which were not included
in the calculation of diluted earnings per shares as their inclusion would have been anti-dilutive. |
|